Cytek Biosciences shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Cytek Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Cytek Biosciences held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytek Biosciences by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.0M | 328k | 9.12 |
| 2023-09-30 | $1.8M | 322k | 5.52 |
| 2023-06-30 | $2.5M | 290k | 8.54 |
| 2023-03-31 | $1.4M | 149k | 9.19 |
| 2022-12-31 | $1.5M | 143k | 10.21 |
| 2022-09-30 | $2.1M | 141k | 14.72 |
| 2022-06-30 | $1.4M | 129k | 10.73 |
| 2022-03-31 | $1.0M | 96k | 10.78 |
| 2021-12-31 | $242k | 15k | 16.33 |
| 2021-09-30 | $252k | 12k | 21.43 |